Renalytix Plc reported earnings results for the third quarter and nine months ended March 31, 2022. For the third quarter, the company reported sales was USD 0.812 million compared to USD 0.619 million a year ago. Net loss was USD 14.7 million compared to USD 8.78 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.12 a year ago.
For the nine months, sales was USD 2.14 million compared to USD 1.02 million a year ago. Net loss was USD 40.12 million compared to USD 24.91 million a year ago. Basic loss per share from continuing operations was USD 0.56 compared to USD 0.35 a year ago.